Literature DB >> 1532409

Clarithromycin-minocycline is synergistic in a murine model of toxoplasmosis.

F G Araujo, P Prokocimer, J S Remington.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1532409     DOI: 10.1093/infdis/165.4.788

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  6 in total

1.  The ketolide antibiotics HMR 3647 and HMR 3004 are active against Toxoplasma gondii in vitro and in murine models of infection.

Authors:  F G Araujo; A A Khan; T L Slifer; A Bryskier; J S Remington
Journal:  Antimicrob Agents Chemother       Date:  1997-10       Impact factor: 5.191

2.  Rifabutin is active in murine models of toxoplasmosis.

Authors:  F G Araujo; T Slifer; J S Remington
Journal:  Antimicrob Agents Chemother       Date:  1994-03       Impact factor: 5.191

3.  Clarithromycin, minocycline, and rifabutin treatments before and after infection of C57BL/6 mice with Mycobacterium avium.

Authors:  T Lazard; C Perronne; J Grosset; J L Vilde; J J Pocidalo
Journal:  Antimicrob Agents Chemother       Date:  1993-08       Impact factor: 5.191

Review 4.  Clarithromycin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic potential.

Authors:  D H Peters; S P Clissold
Journal:  Drugs       Date:  1992-07       Impact factor: 9.546

5.  Activity of clarithromycin alone or in combination with other drugs for treatment of murine toxoplasmosis.

Authors:  F G Araujo; P Prokocimer; T Lin; J S Remington
Journal:  Antimicrob Agents Chemother       Date:  1992-11       Impact factor: 5.191

6.  Synergistic activity of clarithromycin and minocycline in an animal model of acute experimental toxoplasmosis.

Authors:  F Derouin; B Caroff; F Chau; P Prokocimer; J J Pocidalo
Journal:  Antimicrob Agents Chemother       Date:  1992-12       Impact factor: 5.191

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.